Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 242-367-1 | CAS number: 18480-07-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1996-11-25 to 1997-01-05
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Guideline study with restrictions Minor deviations with no effect on the results: The purity and stability of the test material was not stated. According to the guideline, the Magnusson and Kligman grading scale for the evaluation of challenge patch test reactions should be used for evaluating skin reactions. In this study this grading scale was not used, but only the grading according to Draize. Nevertheless, this deviation from the guideline has no effect on the results since no skin reactions were observed during the study.
Cross-reference
- Reason / purpose for cross-reference:
- read-across: supporting information
Reference
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
Further information is included as attachment in Section 13. - Reason / purpose for cross-reference:
- read-across source
- Group:
- positive control
- Remarks on result:
- other: No positive control animal group included
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 50 % w/w of strontium chloride-6-hydrate extra pure
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No skin reactions were noted.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 25 % w/w of strontium chloride-6-hydrate extra pure
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No skin reactions were noted.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50 % w/w of strontium chloride-6-hydrate extra pure
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No skin reactions were noted.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25 % w/w of strontium chloride-6-hydrate extra pure
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No skin reactions were noted.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 50 % w/w of strontium chloride-6-hydrate extra pure
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No other skin reactions were noted.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 25 % w/w of strontium chloride-6-hydrate extra pure
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No other skin reactions were noted.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 50 % w/w of strontium chloride-6-hydrate extra pure
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No other skin reactions were noted.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 25 % w/w of strontium chloride-6-hydrate extra pure
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No other skin reactions were noted
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Based on the read-across from SrCl2, Strontium hydroxide is not expected to be a skin sensitizer and therefore is not classified as Category 1.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 997
- Report date:
- 1997
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- , adopted 1992-07-17
- Deviations:
- yes
- Remarks:
- , see "rationale for reliability"
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- signed 1996-02-27
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- At the time of testing (1997), the LLNA method was not yet adopted as OECD Guideline and not yet identified as the standard information requirement.
For this reason the use of the guinea pig maximisation test (GPMT) was considered te be acceptable.
Test material
- Reference substance name:
- Strontium chloride hexahydrate
- EC Number:
- 600-046-7
- Cas Number:
- 10025-70-4
- Molecular formula:
- Cl2-Sr.6H2-O
- IUPAC Name:
- Strontium chloride hexahydrate
- Reference substance name:
- Strontium dichloride hexahydrate
- IUPAC Name:
- Strontium dichloride hexahydrate
- Test material form:
- solid: crystalline
- Details on test material:
- - Name of test material (as cited in study report): Strontium chloride-6-hydrate extra pure
- EC number: 233-971-6
- Physical state: White crystalline solid
- Storage condition of test material: Ambient temperature (< 25 °C), under artificial light
No further information on the test material was stated.
Constituent 1
Constituent 2
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: David Hall Limited, Burton-on-Trent, Staffordshire, UK (Albino Dunkin Hartley guinea pigs)
- Age at study initiation: Approximately eight to twelve weeks old
- Weight at study initiation: 380 to 483 g (The bodyweight of one animal was above the weight range specified in the study protocol (450 g). According to the author of this study report, this deviation was considered not to affect the purpose or integrity of the study.)
- Housing: The animals were housed singly or in pairs in solid-floor polypropylene cages furnished with woodflakes.
- Diet (ad libitum): Guinea Pig FD1 Diet, Special Diets Services Limited, Witham, Essex, UK
- Water (ad libitum): Mains tap water
- Acclimation period: At least five days
ENVIRONMENTAL CONDITIONS
- Temperature: 19 to 21 °C
- Relative humidity: 41 to 59 %
- Air exchanges: Approximately fifteen changes per hour
- Photoperiod (hrs dark / hrs light): 12/12
No further information on the test animals was stated.
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- water
- Concentration / amount:
- Main study (selection of concentration based on sighting test):
Intradermal induction: 5 % w/v in distilled water
Topical induction: 50 % w/w in distilled water
Topical challenge: 50 % and 25 % w/w in distilled water
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- Main study (selection of concentration based on sighting test):
Intradermal induction: 5 % w/v in distilled water
Topical induction: 50 % w/w in distilled water
Topical challenge: 50 % and 25 % w/w in distilled water
- No. of animals per dose:
- Main study:
Test group: 10 animals
Control group: 5 animals - Details on study design:
- RANGE FINDING TESTS:
The concentrations of test material to be used at each stage of the main study were determined by 'sighting tests' in which groups of guinea pigs were treated with various concentrations of test material. The procedures were as follows:
- Selection of concentration for intradermal induction:
Four concentrations of test material were investigated (1 %, 5 %, 10 % and 25 % w/v in distilled water). A total of four guinea pigs were used, each guinea pig receiving four 0.1 ml injections of only one concentration of test material. The degree of erythema at the injection sites was assessed approximately 24, 48 and 72 hours and 7 days after injection according to the Draize scoring system. The degree of oedema was not evaluated. Any evidence of systemic toxicity was also recorded. The highest concentration that caused only mild to moderate skin irritation, and which was well tolerated systemically, was selected for the intradermal induction stage of the main study.
- Selection of concentration for topical induction:
Two guinea pigs (intradermally injected with Freund's Complete Adjuvant ten days earlier) were treated with four preparations of the test material (50 %, 25 %, 10 % and 5 % w/w in distilled water). Applications were made to the clipped flanks under occlusive dressings for an exposure period of 48 hours. The degree of erythema and oedema was evaluated approximately 1, 24 and 48 hours after dressing removal. The highest concentration producing only mild to moderate dermal irritation was selected for the topical induction stage of the main study.
- Selection of concentration for topical challenge:
Four preparations of the test material (50 %, 25 %, 10 % and 5 % w/w in distilled water) were applied to the clipped flanks of two guinea pigs under occlusive dressings for an exposure period of 24 hours. These guinea pigs did not form part of the main study but had been treated identically to the control animals of the main study, up to Day 15. The degree of erythema and oedema was evaluated approximately 1, 24 and 48 hours after dressing removal. The highest non-irritant concentration of the test material and one lower concentration were selected for the topical challenge stage of the main study.
MAIN STUDY
Two main phases were involved in the main study; a) an induction of a response and b) a challenge of that response. The bodyweight of each animal was recorded at the start and end of the study.
A. INDUCTION EXPOSURE - TEST GROUP
Shortly before treatment on Day 0 the hair was removed from an area approximately 40 mm X 60 mm on the shoulder region of each animal with veterinary clippers. A row of three injections (0.1 ml each) was made on each side of the mid-line. The injections were:
a). Freund's Complete Adjuvant plus distilled water in the ratio 1:1
b) a 5 % w/v solution of the test material in distilled water
c) a 5 % w/v emulsion of the test material in a 1:1 preparation of Freund's Complete Adjuvant plus distilled water.
Approximately 24 and 48 hours after intradermal injection the degree of erythema at the test material injection sites (i.e. injection site b) was evaluated according to the Draize scoring system.
One week later (Day 7), the same area on the shoulder region used previously for intradermal injections was clipped again and treated with a topical application of the test material formulation. A filter paper patch (WHATMAN No. 4: approximate size 40 mm X 20 mm), loaded with the test material formulation (50 % w/v in distilled water) as a thick, even layer was applied to the prepared skin and held in place with a strip of surgical adhesive tape (BLENDERM: approximate size 50 mm X 30 mm) covered with an overlapping length of aluminium foil. The patch and foil were further secured with a strip of elastic adhesive bandage (ELASTOPLAST: approximate size 250 mm X 35 mm) wound in a double layer around the torso of each animal. This occlusive dressing was kept in place for 48-hours.
The degree of erythema and oedema was quantified one and twenty-four hours following removal of the patches using the Draize scoring system.
Any other reactions were also recorded.
B. INDUCTION EXPOSURE - CONTROL GROUP
Intradermal injections were administered using an identical procedure to that used for the test animals, except that the injections were:
a) Freund's Complete Adjuvant plus distilled water in the ratio 1:1
b) distilled water
c) a 50 % w/v formulation distilled water in Freund's Complete Adjuvant/distilled water 1 :1
The topical applications followed the same procedure as for the test animals except that the vehicle alone was applied to the filter paper.
Skin reactions were quantified as for the test animals.
C. CHALLENGE EXPOSURE
Shortly before treatment on Day 21, an area of approximately 50 mm X 70 mm on both flanks of each animal, was clipped free of hair with veterinary clippers.
A square filter paper patch (WHATMAN No.4 approximate size 20 mm X 20 mm), loaded with a thick, even layer of test material at the maximum non-irritant concetration (50 % w/w in distilled water) was applied to the shorn right flank of each animal and was held in place with a strip of surgical adhesive tape (BLENDERM: approximate size 40 mm X 50 mm). To ensure that the maximum non-irritant concentration was used at challenge, the test material at a concentration of 25 % w/w in distilled water was similarly applied to skin site on the left shorn flank. The patches were occluded with an overlapping length of aluminium foil and secured with a strip of elastic adhesive bandage (ELSTOPLAST: approximate size 250 mm X 75 mm) wound in a double layer around the torso of each animal.
After 24 hours, the dressing was carefully cut using blunt-tipped scissors, removed and discarded. The challenge sites were swabbed with cotton wool soaked in distilled water to remove residual material.
Prior to the 24 hours observation the flanks were clipped using veterinary clippers to remove regrown hair.
EVALUATION OF SKIN REACTIONS
Approximately 24 and 48 hours after challenge dressing removal, the degree of erythema and oedema was quantified using the Draize scoring system.
Any other reactions were also recorded.
No further information on the study design was stated. - Challenge controls:
- Control group: Distilled water
5 animals were used for the control group - Positive control substance(s):
- yes
- Remarks:
- see attachment under "attached background material"
Results and discussion
- Positive control results:
- see attachment under "attached background material"
In vivo (non-LLNA)
Resultsopen allclose all
- Group:
- positive control
- Remarks on result:
- other: No positive control animal group included
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 50 % w/w of strontium chloride-6-hydrate extra pure
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No skin reactions were noted.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 25 % w/w of strontium chloride-6-hydrate extra pure
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No skin reactions were noted.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50 % w/w of strontium chloride-6-hydrate extra pure
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No skin reactions were noted.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25 % w/w of strontium chloride-6-hydrate extra pure
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No skin reactions were noted.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 50 % w/w of strontium chloride-6-hydrate extra pure
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No other skin reactions were noted.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 25 % w/w of strontium chloride-6-hydrate extra pure
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No other skin reactions were noted.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 50 % w/w of strontium chloride-6-hydrate extra pure
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No other skin reactions were noted.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 25 % w/w of strontium chloride-6-hydrate extra pure
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No other skin reactions were noted
Any other information on results incl. tables
Skin reactions observed after intradermal induction:
Very slight erythema was noted at the intradermal induction sites of eight test group animals at the 24 hour observation and in four test group animals at the 48 -hour observation.
Very slight erythema was noted at the intradermal induction sites of three control group animals at the 24 -hour observation. no skin reactions were noted at the intradermal induction sites of control group animals at the 48 hour observation.
Skin reactions observed after topical induction:
Very slight erythema was noted at the induction sites of five test group animals at the 1 -hour observation and persisted in one test group animal at the 24 -hour observation.
No skin reactions were noted at the treatment sites of control group animals at the 1 and 24 -hour observations.
Bodyweight
Bodyweight gains of guinea pigs in the test group, between Day 0 and Day 24, were comparable to those observed in the control group animals over the same period.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test material, Strontium chloride-6-hydrate extra pure, produced a 0 % (0/10) sensitisation rate and was classified as a non-sensitiser to guinea pig skin.
According to the EC Regulation No. 1272/2008 and subsequent regulations, the test item is not classified as Category 1.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.